Economic portfolio
ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETF
ABSL Aditya Birla Sun Life Mutual Fund Jan 2022 — Sep 2026 57 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 0.1 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
57 priced months, Jan 2022 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
75.9% now, 76.7% in Sep 2025 · highest 83.8%, lowest 75.9%
Companies held
20 now, 20 in Sep 2025 · largest single holding 17.0% of equity
How it trades: no clear lean toward recent winners or losers (score +0.02 over 47 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- Axis NIFTY Healthcare ETFAxis · 20 shared99.9%
- DSP Nifty Healthcare Index FundDSP · 20 shared99.9%
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 20 shared99.9%
- DSP Nifty Healthcare ETFDSP · 20 shared99.9%
- EODWHFEdelweiss · 18 shared91.8%
- Nippon India Nifty Pharma ETFNippon India · 16 shared81.1%
- ICICI Prudential Nifty Pharma Index FundICICI Prudential · 16 shared81.1%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 20 shared79.8%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
Largest increases
- None this month.
Largest reductions
- 01 Sun Pharmaceutical Industries Limited-8.0% -6,098
- 02 Biocon Limited-10.2% -5,216
- 03 Max Healthcare Institute Limited-8.1% -4,318
- 04 Dr. Reddy's Laboratories Limited-8.0% -3,511
- 05 Cipla Limited-8.0% -3,239
- 06 Fortis Healthcare Limited-8.1% -3,038
- 07 Laurus Labs Limited-7.9% -2,219
- 08 Zydus Lifesciences Limited-9.1% -1,637
- 09 Aurobindo Pharma Limited-8.2% -1,636
- 10 Lupin Limited-8.2% -1,425
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 17.00% | 12.69 Cr | 69,877 | by Jan 2022 (57 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 10.46% | 7.81 Cr | 8,407 | by Jan 2022 (57 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 7.45% | 5.56 Cr | 6,815 | by Jan 2022 (57 mo+) |
| Laurus Labs Limited | Healthcare | Mid Cap | 6.82% | 5.09 Cr | 25,698 | by Jan 2022 (57 mo+) |
| Cipla Limited | Healthcare | Large Cap | 6.70% | 5.00 Cr | 37,134 | by Jan 2022 (57 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 6.64% | 4.96 Cr | 40,227 | by Jan 2022 (57 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 6.26% | 4.68 Cr | 9,741 | by Jan 2022 (57 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 6.11% | 4.56 Cr | 49,081 | Mar 2023 (43 mo) |
| Lupin Limited | Healthcare | Mid Cap | 4.35% | 3.25 Cr | 16,000 | by Jan 2022 (57 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 4.08% | 3.05 Cr | 18,224 | by Jan 2022 (57 mo+) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 3.54% | 2.65 Cr | 34,353 | Mar 2025 (19 mo) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 3.10% | 2.31 Cr | 9,909 | by Jan 2022 (57 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 2.77% | 2.07 Cr | 4,008 | by Jan 2022 (57 mo+) |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 2.54% | 1.90 Cr | 16,315 | by Jan 2022 (57 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 2.50% | 1.87 Cr | 7,451 | Mar 2025 (19 mo) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 2.36% | 1.76 Cr | 9,146 | by Jan 2022 (57 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 2.28% | 1.70 Cr | 45,976 | by Jan 2022 (57 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 2.04% | 1.52 Cr | 5,254 | Sep 2026 (1 mo) |
| Krishna Institute of Medical Sciences Limited | Healthcare | Small Cap | 1.76% | 1.31 Cr | 17,576 | Sep 2026 (1 mo) |
| Abbott India Limited | Healthcare | Mid Cap | 1.22% | 0.91 Cr | 337 | Mar 2022 (55 mo) |
Half of its current holdings have been held for 57 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Piramal Pharma Limited | Sep 2026 | ▼ Complete exit | -44,629 |
| Krishna Institute of Medical Sciences Limited | Sep 2026 | ▲ New position | +17,576 |
| Syngene International Limited | Sep 2026 | ▼ Complete exit | -13,642 |
| Sun Pharmaceutical Industries Limited | Sep 2026 | ▼ Reducing | -6,098 |
| Gland Pharma Limited | Sep 2026 | ▲ New position | +5,254 |
| Biocon Limited | Sep 2026 | ▼ Reducing | -5,216 |
| Max Healthcare Institute Limited | Sep 2026 | ▼ Reducing | -4,318 |
| Dr. Reddy's Laboratories Limited | Sep 2026 | ▼ Reducing | -3,511 |
| Cipla Limited | Sep 2026 | ▼ Reducing | -3,239 |
| Fortis Healthcare Limited | Sep 2026 | ▼ Reducing | -3,038 |
| Laurus Labs Limited | Sep 2026 | ▼ Reducing | -2,219 |
| Zydus Lifesciences Limited | Sep 2026 | ▼ Reducing | -1,637 |
| Aurobindo Pharma Limited | Sep 2026 | ▼ Reducing | -1,636 |
| Lupin Limited | Sep 2026 | ▼ Reducing | -1,425 |
| Glenmark Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -894 |
| IPCA Laboratories Limited | Sep 2026 | ▼ Reducing | -821 |
| Torrent Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -783 |
| Divi's Laboratories Limited | Sep 2026 | ▼ Reducing | -710 |
| Mankind Pharma Limited | Sep 2026 | ▼ Reducing | -673 |
| Apollo Hospitals Enterprise Limited | Sep 2026 | ▼ Reducing | -567 |
| Alkem Laboratories Limited | Sep 2026 | ▼ Reducing | -189 |
| Abbott India Limited | Sep 2026 | ▼ Reducing | -36 |
| Sun Pharmaceutical Industries Limited | Aug 2026 | ▲ Increasing | +473 |
| Max Healthcare Institute Limited | Aug 2026 | ▲ Increasing | +333 |
| Biocon Limited | Aug 2026 | ▲ Increasing | +318 |
| Piramal Pharma Limited | Aug 2026 | ▲ Increasing | +277 |
| Dr. Reddy's Laboratories Limited | Aug 2026 | ▲ Increasing | +273 |
| Cipla Limited | Aug 2026 | ▲ Increasing | +252 |
| Fortis Healthcare Limited | Aug 2026 | ▲ Increasing | +232 |
| Laurus Labs Limited | Aug 2026 | ▲ Increasing | +173 |
| Aurobindo Pharma Limited | Aug 2026 | ▲ Increasing | +123 |
| Zydus Lifesciences Limited | Aug 2026 | ▲ Increasing | +110 |
| Lupin Limited | Aug 2026 | ▲ Increasing | +107 |
| Syngene International Limited | Aug 2026 | ▲ Increasing | +83 |
| Glenmark Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +67 |
| Torrent Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +65 |
| IPCA Laboratories Limited | Aug 2026 | ▲ Increasing | +61 |
| Divi's Laboratories Limited | Aug 2026 | ▲ Increasing | +58 |
| Mankind Pharma Limited | Aug 2026 | ▲ Increasing | +49 |
| Apollo Hospitals Enterprise Limited | Aug 2026 | ▲ Increasing | +47 |
| Alkem Laboratories Limited | Aug 2026 | ▲ Increasing | +26 |
| Abbott India Limited | Aug 2026 | ▲ Increasing | +2 |
| Sun Pharmaceutical Industries Limited | Jul 2026 | ▼ Reducing | -4,181 |
| Max Healthcare Institute Limited | Jul 2026 | ▼ Reducing | -2,939 |
| Biocon Limited | Jul 2026 | ▼ Reducing | -2,815 |
| Torrent Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +2,562 |
| Piramal Pharma Limited | Jul 2026 | ▼ Reducing | -2,453 |
| Dr. Reddy's Laboratories Limited | Jul 2026 | ▼ Reducing | -2,407 |
| Cipla Limited | Jul 2026 | ▼ Reducing | -2,222 |
| Fortis Healthcare Limited | Jul 2026 | ▼ Reducing | -2,056 |
| Laurus Labs Limited | Jul 2026 | ▼ Reducing | -1,535 |
| Aurobindo Pharma Limited | Jul 2026 | ▼ Reducing | -1,092 |
| Zydus Lifesciences Limited | Jul 2026 | ▼ Reducing | -985 |
| Lupin Limited | Jul 2026 | ▼ Reducing | -957 |
| Syngene International Limited | Jul 2026 | ▼ Reducing | -747 |
| Glenmark Pharmaceuticals Limited | Jul 2026 | ▼ Reducing | -594 |
| IPCA Laboratories Limited | Jul 2026 | ▼ Reducing | -547 |
| Divi's Laboratories Limited | Jul 2026 | ▼ Reducing | -504 |
| Mankind Pharma Limited | Jul 2026 | ▼ Reducing | -444 |
| Apollo Hospitals Enterprise Limited | Jul 2026 | ▼ Reducing | -409 |
| Alkem Laboratories Limited | Jul 2026 | ▼ Reducing | -232 |
| Abbott India Limited | Jul 2026 | ▼ Reducing | -21 |
| Sun Pharmaceutical Industries Limited | Jun 2026 | ▲ Increasing | +1,613 |
| Max Healthcare Institute Limited | Jun 2026 | ▲ Increasing | +1,142 |
| Piramal Pharma Limited | Jun 2026 | ▲ Increasing | +1,116 |
| Biocon Limited | Jun 2026 | ▲ Increasing | +1,065 |
| Dr. Reddy's Laboratories Limited | Jun 2026 | ▲ Increasing | +940 |
| Cipla Limited | Jun 2026 | ▲ Increasing | +861 |
| Fortis Healthcare Limited | Jun 2026 | ▲ Increasing | +791 |
| Laurus Labs Limited | Jun 2026 | ▲ Increasing | +591 |
| Lupin Limited | Jun 2026 | ▲ Increasing | +392 |
| Zydus Lifesciences Limited | Jun 2026 | ▲ Increasing | +382 |
| Syngene International Limited | Jun 2026 | ▲ Increasing | +315 |
| Glenmark Pharmaceuticals Limited | Jun 2026 | ▲ Increasing | +229 |
| Aurobindo Pharma Limited | Jun 2026 | ▲ Increasing | +218 |
| IPCA Laboratories Limited | Jun 2026 | ▲ Increasing | +213 |
| Divi's Laboratories Limited | Jun 2026 | ▲ Increasing | +193 |
| Torrent Pharmaceuticals Limited | Jun 2026 | ▲ Increasing | +185 |
| Mankind Pharma Limited | Jun 2026 | ▲ Increasing | +177 |
| Apollo Hospitals Enterprise Limited | Jun 2026 | ▲ Increasing | +157 |
| Alkem Laboratories Limited | Jun 2026 | ▲ Increasing | +89 |
| Abbott India Limited | Jun 2026 | ▲ Increasing | +8 |
| Sun Pharmaceutical Industries Limited | May 2026 | ▼ Reducing | -366 |
| Max Healthcare Institute Limited | May 2026 | ▼ Reducing | -258 |
| Biocon Limited | May 2026 | ▼ Reducing | -246 |
| Piramal Pharma Limited | May 2026 | ▼ Reducing | -215 |
| Dr. Reddy's Laboratories Limited | May 2026 | ▼ Reducing | -211 |
| Cipla Limited | May 2026 | ▼ Reducing | -195 |
| Fortis Healthcare Limited | May 2026 | ▼ Reducing | -180 |
| Laurus Labs Limited | May 2026 | ▼ Reducing | -135 |
| Aurobindo Pharma Limited | May 2026 | ▼ Reducing | -97 |
| Zydus Lifesciences Limited | May 2026 | ▼ Reducing | -86 |
| Lupin Limited | May 2026 | ▼ Reducing | -84 |
| Syngene International Limited | May 2026 | ▼ Reducing | -66 |
| Glenmark Pharmaceuticals Limited | May 2026 | ▼ Reducing | -53 |
| IPCA Laboratories Limited | May 2026 | ▼ Reducing | -48 |
| Divi's Laboratories Limited | May 2026 | ▼ Reducing | -44 |
| Mankind Pharma Limited | May 2026 | ▼ Reducing | -39 |
| Torrent Pharmaceuticals Limited | May 2026 | ▼ Reducing | -36 |
| Apollo Hospitals Enterprise Limited | May 2026 | ▼ Reducing | -35 |
Changes compare consecutive month-end disclosures for this portfolio only.